(Based on Intent To Use) Pharmaceutical preparations, namely, RNA-based therapeutics for use in the treatment of complement-mediated, immune-related, genetic, cardiovascular, central nervous system, and metabolic diseases, conditions, and disorders, and cancer

'base':1,11 'cancer':37 'cardiovascular':26 'central':27 'complement':20 'complement-medi':19 'condit':33 'diseas':32 'disord':35 'genet':25 'immun':23 'immune-rel':22 'intent':3 'mediat':21 'metabol':31 'name':8 'nervous':28 'pharmaceut':6 'prepar':7 'relat':24 'rna':10 'rna-bas':9 'system':29 'therapeut':12 'treatment':17 'use':5,14

(Based on Intent To Use) Nucleotides for scientific and research use; nucleotides for use in the manufacture of pharmaceuticals

'base':1 'intent':3 'manufactur':17 'nucleotid':6,12 'pharmaceut':19 'research':10 'scientif':8 'use':5,11,14

(Based on Use in Commerce) Development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; scientific research and development in the field of RNA-based therapeutics; design and testing of RNA agents; bioinformatics and genomic data analysis for therapeutic development

'agent':36 'analysi':41 'base':1,29 'bioinformat':37 'commerc':5 'data':40 'design':31 'develop':6,14,18,22,44 'field':25 'genom':39 'medicin':11 'pharmaceut':8,12,15 'prepar':9 'product':13 'research':16,20 'rna':28,35 'rna-bas':27 'scientif':19 'test':33 'therapeut':30,43 'use':3

ADARX PHARMACEUTICALS

Owners

Goods & Services